Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Impact of lymphadenectomy and lymphoedema on health-related quality of life 1 year after surgery for endometrial cancer. A prospective longitudinal multicentre study.

Tytuł:
Impact of lymphadenectomy and lymphoedema on health-related quality of life 1 year after surgery for endometrial cancer. A prospective longitudinal multicentre study.
Autorzy:
Wedin M; Department of Obstetrics and Gynaecology in Linköping, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Stålberg K; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Marcickiewicz J; Department of Obstetrics and Gynaecology, Varberg Hospital, Varberg, Sweden.
Ahlner E; Department of Oncology, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Åkesson Å; Department of Obstetrics and Gynaecology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Lindahl G; Department of Oncology, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Wodlin NB; Department of Obstetrics and Gynaecology in Linköping, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Kjølhede P; Department of Obstetrics and Gynaecology in Linköping, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Corporate Authors:
LASEC study group
Źródło:
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2022 Feb; Vol. 129 (3), pp. 450-460. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji:
Journal Article; Multicenter Study
Język:
English
Imprint Name(s):
Publication: : Oxford : Wiley-Blackwell
Original Publication: Oxford [England] : Blackwell Science, [2000]-
MeSH Terms:
Lymph Node Excision*
Quality of Life*
Endometrial Neoplasms/*surgery
Lymphedema/*epidemiology
Postoperative Complications/*epidemiology
Aged ; Cost of Illness ; Female ; Humans ; Longitudinal Studies ; Lymphedema/etiology ; Middle Aged ; Postoperative Complications/etiology ; Postoperative Period ; Prospective Studies ; Surveys and Questionnaires ; Sweden ; Treatment Outcome
References:
Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978-2013. J Natl Cancer Inst 2018;110:354-61.
Zhang S, Gong TT, Liu FH, Jiang YT, Sun H, Ma XX, et al. Global, regional, and national burden of endometrial cancer, 1990-2017: results from the global burden of disease study, 2017. Front Oncol 2019;9:1440.
The National Board of Health and Welfare in Sweden. Official Statistics of Sweden. [https://www.socialstyrelsen.se/en/statistics-and-data/statistics/]. (Published:2019-04-15; Last updated: 2020-12-02 Accessed 19 December 2020.
Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
ASTEC study group; Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2017;10(10):CD007585.
Joly F, McAlpine J, Nout R, Åvall-Lundqvist E, Shash E, Friedlander M. Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action! Int J Gynecol Cancer 2014;24:1693-9.
Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Lower body lymphedema in patients with gynecologic cancer. Anticancer Res 2017;37:4005-15.
Finnane A, Hayes SC, Obermair A, Janda M. Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcomes Res 2011;11:287-97.
Dunberger G, Lindquist H, Waldenström AC, Nyberg T, Steineck G, Åvall-Lundqvist E. Lower limb lymphedema in gynecological cancer survivors-effect on daily life functioning. Support Care Cancer 2013;21:3063-70.
Angioli R, Plotti F, Cafà EV, Dugo N, Capriglione S, Terranova C, et al. Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy. Eur J Obstet Gynecol Reprod Biol 2013;170:539-43.
Yost KJ, Cheville AL, Al-Hilli MM, Mariani A, Barrette BA, McGree ME, et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol 2014;124(2 Pt 1):307-15.
Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA, et al. Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecol Oncol 2014;133:314-8.
Biglia N, Librino A, Ottino MC, Panuccio E, Daniele A, Chahin A. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer. Int J Gynecol Cancer 2015;25:521-5.
Kim SI, Lim MC, Lee JS, Lee Y, Park K, Joo J, et al. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection. Eur J Obstet Gynecol Reprod Biol 2015;192:31-6.
Wedin M, Stålberg K, Marcickiewicz J, Ahlner E, Åkesson Å, Lindahl G, et al. Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: a prospective longitudinal multicenter study. Gynecol Oncol 2020;159:201-8.
Swedish National guidelines for endometrial cancer (Nationellt vårdprogram livmodercancer] (In Swedish); 2012. [https://www.cancercentrum.se/globalassets/cancerdiagnoser/gynekologi/livmoderkroppscancer/vardprogram/nationellt-vardprogram-endometriecancer.pdf]. up-dated 2017, 2018 and 2020 [Accessed 19 December 2020].
Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.
Burström K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001;10:621-35.
Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349-58.
Keeley V, Crooks S, Locke J, Veigas D, Debbie RK, William R. A quality of life measure for limb lymphedema (LYMQOL). J Lymphoedema 2010;5:26-37.
Wedin M, Fredrikson M, Ahlner E, Falk A, Sandström Å, Lindahl G, et al. Validation of the lymphoedema quality of life questionnaire (LYMQOL) in Swedish cancer patients. Acta Oncol 2020;59:365-71.
Sitzia J. Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care (Engl) 1995;4:11-6.
Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg 2014;134:154e-60.
Bruna J, Miller AJ, Beninson J. A simple clinical classification of lymphedema. Eur J Plast Surg 1999;22:404-5.
van de Pas CB, Biemans AA, Boonen RS, Viehoff PB, Neumann HA. Validation of the lymphoedema quality-of-life questionnaire (LYMQOL) in Dutch patients diagnosed with lymphoedema of the lower limbs. Phlebology 2016;31:257-63.
Borman P, Yaman A, Denizli M, Karahan S. The reliability and validity of lymphedema quality of life questionnaire-leg in Turkish patients with lower limb lymphedema. Lymphat Res Biol 2020;18:42-8.
Ware JE Jr, Gandek B, Guyer R, Deng N. Standardizing disease-specific quality of life measures across multiple chronic conditions: development and initial evaluation of the QOL Disease Impact Scale (QDIS®). Health Qual Life Outcomes 2016;14:84.
Geppert B, Lönnerfors C, Bollino M, Persson J. Sentinel lymph node biopsy in endometrial cancer - Feasibility, safety and lymphatic complications. Gynecol Oncol 2018;148:491-8.
Grant Information:
LUL-349271 Uppsala-Örebro Regional Research Council; CAN2013/620 The Swedish Cancer Society (Cancerfonden); FORSS-308611 The Medical Research Council of Southeast Sweden; FORSS-391311 The Medical Research Council of Southeast Sweden; FORSS-662141 The Medical Research Council of Southeast Sweden; FORSS-858611 The Medical Research Council of Southeast Sweden; Scientific Council of the Region Halland; County Council of Östergötland; Linköping University
Contributed Indexing:
Keywords: Endometrial cancer; health-related quality-of-life; lower limb; lymphadenectomy; lymphoedema
Entry Date(s):
Date Created: 20210826 Date Completed: 20220124 Latest Revision: 20220430
Update Code:
20240104
DOI:
10.1111/1471-0528.16870
PMID:
34437763
Czasopismo naukowe
Objective: To assess the impact of lymphadenectomy and lymphoedema of the lower limbs (LLL) on health-related quality of life (HRQoL) 1 year after surgery for endometrial cancer (EC).
Design: Prospective longitudinal cohort multicentre study.
Setting: Departments of obstetrics and gynaecology at four university hospitals, six central hospitals and four county hospitals in Sweden.
Population: Two-hundred-and-thirty-five women with early stage EC were included; 116 with high-risk EC underwent surgery including lymphadenectomy (+LA), and 119 with low-risk EC had surgery without lymphadenectomy (-LA).
Methods: The generic SF-36 and EQ-5D-3L and the lymphoedema-specific LYMQOL questionnaire were used to assess HRQoL. LLL was assessed by systematic circumferential measurements of the legs enabling volume estimation, clinical evaluation and patient-reported perception of leg swelling. All assessments were carried out on four occasions; preoperatively, and 4-6 weeks, 6 months and 1 year postoperatively.
Main Outcome Measure: HRQoL scores.
Results: No significant differences were seen in HRQoL between the +LA and -LA groups 1 year postoperatively. Irrespective of method of determining LLL, women with LLL were significantly more affected in the LYMQOL domains Function, Appearance/body image and Physical symptoms, but not in the domain Emotion/mood, than women without LLL. No such differences were seen in the generic HRQoL or in the LYMQOL global score between the groups with and without LLL.
Conclusions: Lymphadenectomy did not seem to affect generic HRQoL adversely. Irrespective of the method of measuring, LLL affected the lymphoedema-specific HRQoL negatively, mainly in physical domains, but had no impact on the generic HRQoL.
Tweetable Abstract: Lymphoedema has impact on lymphoedema-specific, but not on generic, HRQoL, 1 year after surgery for EC.
(© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies